| Name | Shares allotted | % of global offering | % of post-IPO shares | Lock-up |
|---|---|---|---|---|
| Ally Bridge LB Healthcare Master Fund Limited | 0 | 3.99% | — | 6 months |
| Boyu Capital Opportunities Master Fund | 0 | 5.99% | — | 6 months |
| Cormorant Asset Management, LP | 0 | 2.50% | — | 6 months |
| GIC Private Limited | 0 | 6.99% | — | 6 months |
| Hillhouse Funds | 0 | 2.91% | — | 6 months |
| Prime Capital Funds | 0 | 3.99% | — | 6 months |
| Vivo Funds | 0 | 2.00% | — | 6 months |
| Worldwide Healthcare Trust PLC | 0 | 3.99% | — | 6 months |
| 上海医药(香港)投资有限公司 | 0 | 2.00% | — | 6 months |
This page shows allotment analysis for Hansoh Pharma (03692): one-lot hit rate, Pool A/B allotment distribution, oversubscription multiple, and grey-market and first-day performance. Data is parsed from the HKEX allotment results announcement. How allotment rates and clawback work is explained in How Hong Kong IPO Allotment Rates Work.

